Aditya Birla Sun Life Pharma & Healthcare Fund - IDCW - Direct Plan

Other Plans and Options
  • 0.26 %Nav, as on 10-06-2025

  • Previous Nav

  • Net Change on 10-06-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Aditya Birla Sun Life Pharma and Healthcare Fund-Direct - Payout of IDCW 4.33 7.31 13.40 23.88 20.74 22.42
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Aditya Birla Sun Life Pharma and Healthcare Fund-Direct - Payout of IDCW Jul 10, 2019 13.40 23.88 20.74 1.05 814.18
NIPPON INDIA PHARMA FUND - DIRECT Plan - IDCW Option Jan 01, 2013 15.51 25.51 22.69 0.89 8,352.16
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - IDCW Option Jul 13, 2018 24.46 29.61 26.08 1.07 5,507.52
SBI Healthcare Opportunities Fund - Direct Plan - Income Distribution cum Capital Withdrawal Option (IDCW) Jan 01, 2013 22.61 29.36 25.16 0.90 3,689.28
TATA India Pharma & Health Care Fund Direct Plan - Payout of Income Distribution cum capital withdrawal option Dec 28, 2015 16.42 25.65 22.86 0.67 1,231.67
TATA India Pharma & Healthcare Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option Dec 28, 2015 16.42 25.65 22.86 0.67 1,231.67

Fund Holdings as on 31-May-2025

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Apollo Hospitals Enterprise Limited

  • Abbott India Limited

  • Torrent Pharmaceuticals Limited

  • Lupin Limited

  • Fortis Healthcare Limited

  • Ajanta Pharmaceuticals Limited

  • IPCA Laboratories Limited

  • Aurobindo Pharma Limited

  • Alkem Laboratories Limited

  • Mankind Pharma Ltd

  • ALEMBIC PHARMACEUTICALS LIMITED

  • Emcure Pharmaceuticals Ltd

  • J.B. Chemicals & Pharmaceuticals Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • SAI Life Sciences Ltd

  • Jupiter Life Line Hospitals Ltd

  • Clearing Corporation of India Limited

  • Divi's Laboratories Limited

  • Medi Assist Healthcare Services Ltd

  • Dr. Reddys Laboratories Limited

  • Sanofi India Limited

  • METROPOLIS HEALTHCARE LIMITED

  • Procter & Gamble Health Limited

  • Suraksha Diagnostic Ltd

  • Akums Drugs & Pharmaceuticals Ltd

  • SANOFI CONSUMER HEALTHCARE

  • Max Healthcare Institute Limited

  • Vijaya Diagnostic Centre Limited

  • Vinati Organics Limited

  • Net Receivables / (Payables)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Business Support

  • Chemicals

View More

Fund Manager

Most Recent Dividend

  • 24/09/2024

  • 22/09/2023

  • 27/09/2022

  • 28/09/2021

  • 01/10/2020

  • Cash

  • Equity

View More

About Aditya Birla Sun Life Pharma & Healthcare Fund

Scheme Analysis

Aditya Birla Sun Life Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Aditya Birla Sun Life Mutual Fund. It was launched on 10-Jul-2019 and currently has an AUM of ₹814.18 crore. Aditya Birla Sun Life Pharma & Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of Aditya Birla Sun Life Pharma & Healthcare Fund ended up ₹0.06(0.26%)yesterday to ₹22.96.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Aditya Birla Sun Life Pharma & Healthcare Fund is managed by Dhaval Shah and Dhaval Joshi.

Fund House Contact

One World Center , Tower 1, 17th Floor, Jupiter Mill Compound, Senapati Bapat Marg, Elphinstone Road, Mumbai - 400 013

022-43568000
022-43568110/ 8111